Terms: = Prostate cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Diagnosis
17 results:
1. Diagnostic accuracy of qualitative and quantitative magnetic resonance imaging-guided contrast-enhanced ultrasound (MRI-guided CEUS) for the detection of prostate cancer: a prospective and multicenter study.
Liu Y; Lu D; Xu G; Wang S; Zhou B; Zhang Y; Ye B; Xiang L; Zhang Y; Xu H
Radiol Med; 2024 Apr; 129(4):585-597. PubMed ID: 38512615
[TBL] [Abstract] [Full Text] [Related]
2. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge.
Bulten W; Kartasalo K; Chen PC; Ström P; Pinckaers H; Nagpal K; Cai Y; Steiner DF; van Boven H; Vink R; Hulsbergen-van de Kaa C; van der Laak J; Amin MB; Evans AJ; van der Kwast T; Allan R; Humphrey PA; Grönberg H; Samaratunga H; Delahunt B; Tsuzuki T; Häkkinen T; Egevad L; Demkin M; Dane S; Tan F; Valkonen M; Corrado GS; Peng L; Mermel CH; Ruusuvuori P; Litjens G; Eklund M;
Nat Med; 2022 Jan; 28(1):154-163. PubMed ID: 35027755
[TBL] [Abstract] [Full Text] [Related]
3. Androgen deprivation therapy and acute kidney injury in patients with prostate cancer undergoing definitive radiotherapy.
Sherer MV; Deka R; Salans MA; Nelson TJ; Sheridan P; Rose BS
Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):276-281. PubMed ID: 34811501
[TBL] [Abstract] [Full Text] [Related]
4. Concomitant intraductal carcinoma of the prostate and response to hormonal therapy in metastatic prostate carcinoma.
Abascal-Junquera JM; Fumadó-Ciutat L; Gasa-Galmes B; Costa-Planells M; Munarriz-Polo M; Sanromà-Salvà A; Polaina-Barroso L; Solà-Marqués C; Juanpere-Rodero N; Lloreta-Trull J; Cecchini-Rosell L
Actas Urol Esp (Engl Ed); 2021; 45(6):455-460. PubMed ID: 34147428
[TBL] [Abstract] [Full Text] [Related]
5. Identification of a novel non-invasive biological marker to overcome the shortcomings of PSA in diagnosis and risk stratification for prostate cancer: Initial prospective study of developmental endothelial locus-1 protein.
Chung JW; Kim HT; Ha YS; Lee EH; Chun SY; Lee CH; Byeon KH; Choi SH; Lee JN; Kim BS; Kim TH; Yoo ES; Yoon GS; Baek MC; Kwon TG
PLoS One; 2021; 16(4):e0250254. PubMed ID: 33901217
[TBL] [Abstract] [Full Text] [Related]
6. Quality of Life After Bladder cancer: A Cross-sectional Survey of Patient-reported Outcomes.
Catto JWF; Downing A; Mason S; Wright P; Absolom K; Bottomley S; Hounsome L; Hussain S; Varughese M; Raw C; Kelly P; Glaser AW
Eur Urol; 2021 May; 79(5):621-632. PubMed ID: 33581875
[TBL] [Abstract] [Full Text] [Related]
7. Prostatic ductal adenocarcinoma variant predicts worse pathological and oncological outcomes: Insight from over 1000 consecutive patients from a large prospective uro-oncology registry.
Tan YG; Khalid F; Huang HH; Chen K; Tay KJ; Lau WKO; Cheng CWS; Ngo NT; Yuen JSP
Prostate; 2021 Mar; 81(4):242-251. PubMed ID: 33428259
[TBL] [Abstract] [Full Text] [Related]
8. prostate cancer aggressive prediction: preponderant diagnostic performances of intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) beyond ADC at 3.0 T scanner with gleason score at final pathology.
Shan Y; Chen X; Liu K; Zeng M; Zhou J
Abdom Radiol (NY); 2019 Oct; 44(10):3441-3452. PubMed ID: 31144091
[TBL] [Abstract] [Full Text] [Related]
9. Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity.
Franzese C; D'agostino G; Di Brina L; Navarria P; De Rose F; Comito T; Franceschini D; Mancosu P; Tomatis S; Scorsetti M
Br J Radiol; 2019 May; 92(1097):20190021. PubMed ID: 30864833
[TBL] [Abstract] [Full Text] [Related]
10. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
[TBL] [Abstract] [Full Text] [Related]
11. RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for prostate cancer.
Hou Q; Bing ZT; Hu C; Li MY; Yang KH; Mo Z; Xie XW; Liao JL; Lu Y; Horie S; Lou MW
EBioMedicine; 2018 Jun; 32():234-244. PubMed ID: 29861410
[TBL] [Abstract] [Full Text] [Related]
12. Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder.
Chung SD; Kao LT; Lin HC; Xirasagar S; Huang CC; Lee HC
PLoS One; 2017; 12(3):e0173266. PubMed ID: 28253340
[TBL] [Abstract] [Full Text] [Related]
13. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
[TBL] [Abstract] [Full Text] [Related]
14. Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study.
Brunner C; Davies NM; Martin RM; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles G; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Donovan J; Hamdy FC; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; ; Zuccolo L
Int J Cancer; 2017 Jan; 140(1):75-85. PubMed ID: 27643404
[TBL] [Abstract] [Full Text] [Related]
15. The economic burden of skeletal-related events among elderly men with metastatic prostate cancer.
Jayasekera J; Onukwugha E; Bikov K; Mullins CD; Seal B; Hussain A
Pharmacoeconomics; 2014 Feb; 32(2):173-91. PubMed ID: 24435407
[TBL] [Abstract] [Full Text] [Related]
16. Sexually transmissible infections and prostate cancer risk.
Huang WY; Hayes R; Pfeiffer R; Viscidi RP; Lee FK; Wang YF; Reding D; Whitby D; Papp JR; Rabkin CS
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2374-81. PubMed ID: 18768506
[TBL] [Abstract] [Full Text] [Related]
17. Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomy.
Lee LW; McBain CA; Swindell R; Wylie JP; Cowan RA; Logue JP
Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):517-22. PubMed ID: 15630843
[TBL] [Abstract] [Full Text] [Related]
